- Home
- ATRA vs GNTA Comparison
ATRA vs GNTA Comparison
Compare ATRA & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- GNTA
- Stock Information
- Founded
- ATRA 2012
- GNTA 2014
- Country
- ATRA United States
- GNTA Italy
- Employees
- ATRA N/A
- GNTA N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATRA Health Care
- GNTA Health Care
- Exchange
- ATRA Nasdaq
- GNTA Nasdaq
- Market Cap
- ATRA 67.9M
- GNTA 70.6M
- IPO Year
- ATRA 2014
- GNTA 2021
- Fundamental
- Price
- ATRA $12.29
- GNTA $3.50
- Analyst Decision
- ATRA Strong Buy
- GNTA Strong Buy
- Analyst Count
- ATRA 3
- GNTA 1
- Target Price
- ATRA $21.00
- GNTA $25.00
- AVG Volume (30 Days)
- ATRA 65.3K
- GNTA 4.2K
- Earning Date
- ATRA 08-11-2025
- GNTA 01-01-0001
- Dividend Yield
- ATRA N/A
- GNTA N/A
- EPS Growth
- ATRA N/A
- GNTA N/A
- EPS
- ATRA 0.56
- GNTA N/A
- Revenue
- ATRA $188,667,000.00
- GNTA N/A
- Revenue This Year
- ATRA N/A
- GNTA N/A
- Revenue Next Year
- ATRA N/A
- GNTA N/A
- P/E Ratio
- ATRA $21.82
- GNTA N/A
- Revenue Growth
- ATRA 202.41
- GNTA N/A
- 52 Week Low
- ATRA $5.01
- GNTA $2.74
- 52 Week High
- ATRA $18.71
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ATRA 62.30
- GNTA 44.28
- Support Level
- ATRA $10.32
- GNTA $3.20
- Resistance Level
- ATRA $12.31
- GNTA $3.79
- Average True Range (ATR)
- ATRA 0.90
- GNTA 0.21
- MACD
- ATRA -0.04
- GNTA -0.04
- Stochastic Oscillator
- ATRA 77.93
- GNTA 49.40
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.